EUVIMEDEUVIMED entdecken
Crossref

Development of an Adverse Outcome Pathway for the Onset of Hypertension by Oxidative Stress-Mediated Perturbation of Endothelial Nitric Oxide Bioavailability

Frazer J. Lowe, Karsta Luettich, Marja Talikka, Vy Hoang, Linsey E. Haswell, Julia Hoeng, Marianna D. Gaca

Applied In Vitro Toxicology · 2017-03 · 3 (1) · 131-148

DOI: 10.1089/aivt.2016.0031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied In Vitro Toxicology, 2017-03. Verfasst von Frazer J. Lowe und 6 weiteren Autor:innen. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 127 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lowe, F. J., Luettich, K., Talikka, M., Hoang, V., Haswell, L. E., Hoeng, J., & Gaca, M. D. (2017). Development of an Adverse Outcome Pathway for the Onset of Hypertension by Oxidative Stress-Mediated Perturbation of Endothelial Nitric Oxide Bioavailability. Applied In Vitro Toxicology, 3(1), 131-148. https://doi.org/10.1089/aivt.2016.0031

Vancouver

Lowe FJ, Luettich K, Talikka M, Hoang V, Haswell LE, Hoeng J, et al. Development of an Adverse Outcome Pathway for the Onset of Hypertension by Oxidative Stress-Mediated Perturbation of Endothelial Nitric Oxide Bioavailability. Applied In Vitro Toxicology. 2017;3(1):131-148. doi:10.1089/aivt.2016.0031

BibTeX
@article{Lowe2017,
  author = {Lowe, Frazer J. and Luettich, Karsta and Talikka, Marja and Hoang, Vy and Haswell, Linsey E. and Hoeng, Julia and Gaca, Marianna D.},
  title = {Development of an Adverse Outcome Pathway for the Onset of Hypertension by Oxidative Stress-Mediated Perturbation of Endothelial Nitric Oxide Bioavailability},
  journal = {Applied In Vitro Toxicology},
  year = {2017},
  volume = {3},
  number = {1},
  pages = {131--148},
  doi = {10.1089/aivt.2016.0031}
}
Kostenlos starten →